DENTSPLY SIRONA

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic and orthodontic dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Dentsply Sirona (XRAY) exceeds Q4 expectations, focuses on innovation

Dentsply Sirona (XRAY) reported strong financial performance in Q4 2022, with a strategic focus on digitalization and innovation. Despite challenges in organic sales and supply chain constraints, the company aims for margin improvement and growth opportunities through investments and pricing strategies. Restructuring efforts and acquisitions are set to drive profitability and market share gains.

Dentsply Sirona reports robust Q1 growth, eyes digital innovation

Dentsply Sirona's strong Q1 performance driven by Consumables and Aligners segments.
Challenges include mixed regional performance and cautious outlook on equipment demand.
Opportunities lie in digitalization, DSO partnerships, and growth in China and EPS targets.
Overall, a positive outlook with strategic focus on innovation and customer experience.

Dentsply Sirona exceeds Q2 expectations, eyes growth amid challenges

Dentsply Sirona reported strong financial performance in Q2 2023, exceeding expectations and raising full-year outlook across key financial metrics.
The company's strategic focus on growth, profitability, and digitalization, coupled with investments in key regions and product innovation, positions it for sustained success.
While facing challenges in certain markets and operational areas, Dentsply Sirona remains optimistic about opportunities for growth, innovation, and value creation in the dental industry.
Overall, Dentsply Sirona's performance highlights operational strengths, market positioning, and a forward-looking approach to driving shareholder value and market expansion.

DENTSPLY SIRONA reports mixed Q3 results, focuses on innovation and growth

DENTSPLY SIRONA's Q3 performance showed mixed results with challenges in certain markets but strength in key segments like CAD/CAM and Aligners.
The company is focused on driving value through innovation, maintaining a commitment to long-term plans, and navigating external challenges with confidence.
Despite headwinds, DENTSPLY SIRONA remains within guidance range for the year, with a strategic focus on volume growth and market expansion opportunities.

DENTSPLY SIRONA anticipates double-digit EPS growth in 2024

DENTSPLY SIRONA's Q4 2023 performance showed growth in key segments, with strategic initiatives set for 2024 as an inflection year for double-digit EPS growth.
The company is focusing on innovation, SKU optimization, and operational efficiency to drive profitability and revenue growth.
Challenges lie in certain segments and the need for organic growth normalization by 2025, but opportunities exist in new product launches and margin expansion.
Overall, DENTSPLY SIRONA is poised for accelerated profitable growth, with 2024 expected to be a pivotal year for improved performance.

DENTSPLY SIRONA reports mixed Q1 performance amidst innovation focus

DENTSPLY SIRONA navigated challenges in Q1 with a focus on innovation, sustainability, and strategic updates. While facing headwinds in certain segments and markets, the company aims to capitalize on growth opportunities through product launches and strategic initiatives.

DENTSPLY Sirona navigates revenue decline with strategic restructuring plans

DENTSPLY Sirona's Q2 performance reflects revenue decline and margin contraction, prompting strategic restructuring and focus on customer-centric initiatives. While facing challenges from macroeconomic factors and restructuring impacts, the company aims to leverage opportunities in shareholder returns and market dynamics to drive growth and operational efficiency.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Although the revenue and EPS for Dentsply (XRAY) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Dentsply (XRAY) Reports Q4 Earnings: What Key Metrics Have to Say

DENTSPLY SIRONA's (XRAY) Q4 revenues improve year over year. Challenging macro headwinds linger.

DENTSPLY SIRONA (XRAY) Q4 Earnings Beat Estimates, Sales Up Y/Y

Dentsply International (XRAY) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.46 per share a year ago.

Dentsply International (XRAY) Q4 Earnings and Revenues Beat Estimates

Dentsply Sirona posted fourth-quarter profit and revenue that beat Wall Street estimates on Thursday, boosted by strong demand for teeth aligners and dental procedures products.

Dentsply Sirona beats quarterly estimates on strong demand for dental products

CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Eric K. Brandt, who has served as a Director on the Company's Board of Directors (the “Board”) for nearly twenty years and as Chairman of the Board for six years, has informed the Board of his intention to retire at the May 2024 annual meeting and that he will not be standing for re-election.

Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors

CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced its financial results for the fourth quarter and full year of 2023.

Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend

DENTSPLY SIRONA's (XRAY) fourth-quarter 2023 results are likely to reflect a recovery in demand for consumable products, partially offset by lower sales in China due to volume-based procurement policy.

What's in Store for DENTSPLY SIRONA (XRAY) in Q4 Earnings?

Beyond analysts' top -and-bottom-line estimates for Dentsply (XRAY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

Stay Ahead of the Game With Dentsply (XRAY) Q4 Earnings: Wall Street's Insights on Key Metrics

Dentsply (XRAY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Dentsply (XRAY) Beat Estimates Again in Its Next Earnings Report?

CHARLOTTE, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 29, 2024, at 8:30 am ET to review its fourth quarter and full year 2023 financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com.

Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference Call on February 29th

CHARLOTTE, N.C., Jan. 18, 2024 /PRNewswire/ -- Dentsply Sirona today announced that its 2024 DS World Las Vegas event will take place on September 26-28 at Caesars Forum. While the event was previously scheduled to take place in early October, the date was changed in response to customer feedback.

Dentsply Sirona announces that DS World Las Vegas 2024 will take place on September 26-28 at Caesars Forum

CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET). As part of the conference, the Company is providing an update on its 2023 full year anticipated financial results, with net sales expected to be at or above the high end of the Company's previously provided outlook range of $3.90 billion to $3.94 billion. For the full year and fourth quarter 2023, the Company expects to report year-over-year net sales growth in the Essential Dental Solutions, Wellspect Healthcare, and Orthodontic and Implant Solutions segments, partially offset by declines in the Connected Technology Solutions segment. The Company is reaffirming its full year 2023 adjusted EPS outlook range of $1.80 to $1.85 and its expectations for double-digit adjusted EPS growth in 2024. The Company does not provide forward-looking or preliminary estimates of adjusted EPS on a GAAP basis as certain information needed to prepare adjustments is not yet available and cannot be reasonably estimated. A description of the adjustments typically made to compute adjusted EPS can be found in Exhibit 99.1 to the Company's Current Report on Form 8-K filed on November 2, 2023.

Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results

Charlotte, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET).

Dentsply Sirona to Present at the 42nd Annual J.P. Morgan Healthcare Conference

DENTSPLY SIRONA stock (NASDAQ NDAQ : XRAY), a dental consumables and equipment company, trades at $32 per share, about 50% below the level seen in March 2021. XRAY stock was trading at around $36 in early June 2022, just before the Fed started increasing rates, and is now 10% below that level, compared to 20% gains for the S&P 500 during this period.

Will DENTSPLY Stock Rebound To Pre-Inflation Highs Of Over $60?

DENTSPLY SIRONA, Inc. (NASDAQ:XRAY ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Andrea Daley - VP, IR Simon Campion - CEO, President & Director Glenn Coleman - EVP & CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Kevin Caliendo - UBS Jason Bednar - Piper Sandler & Co. Jeffrey Johnson - Robert W. Baird & Co. Jonathan Block - Stifel, Nicolaus & Company Operator Good day, and thank you for standing by.

DENTSPLY SIRONA, Inc. (XRAY) Q3 2023 Earnings Call Transcript

DENTSPLY SIRONA's (XRAY) Q3 revenues are driven by a rise in demand for aligners and CAD/CAM in the United States and a recovery in demand in China. Challenging macro headwinds linger.

DENTSPLY SIRONA (XRAY) Beats on Q3 Earnings, Lowers '23 Guidance

Although the revenue and EPS for Dentsply (XRAY) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Dentsply (XRAY) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

CHARLOTTE, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Mr. Brian Gladden has been appointed to its Board of Directors (the “Board”), effective January 1, 2024, to fill the vacancy from Mr. Harry M. Jansen Kraemer, Jr.'s retirement on December 31, 2023.

Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member

CHARLOTTE, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2023.

Dentsply Sirona Reports Third Quarter 2023 Results

DENTSPLY SIRONA's (XRAY) third-quarter 2023 results are likely to reflect a recovery in demand for consumable products, partially offset by lower sales in China due to volume-based procurement policy.

Is a Beat Likely for DENTSPLY SIRONA (XRAY) in Q3 Earnings?

Dentsply (XRAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Dentsply International (XRAY) Reports Next Week: Wall Street Expects Earnings Growth

Henry Schein

Patterson Companies

Henry Schein has looked to mergers and acquisitions to add revenue growth. Dentsply Sirona grew quarterly earnings per share by 17.6% year over year in the second quarter.

3 Dental Supply Stocks You Can Sink Your Teeth Into

Cooper Companies

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or The Cooper Companies (COO). But which of these two stocks is more attractive to value investors?

XRAY or COO: Which Is the Better Value Stock Right Now?

CHARLOTTE, N.C., Sept. 29, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that, as part of its planned succession process and consistent with the Company's Board of Directors' (the “Board”) commitment to periodic Board refreshment in line with its Corporate Governance Guidelines, the Board has appointed Gregory T. Lucier as Chairman of the Board and as a member of the Corporate Governance and Nominating Committee, effective January 1, 2024. Following six years as Chairman of the Board, Eric K. Brandt will rotate from his role as non-Executive Chairman at the end of the year and will continue to serve as a member of both the Board and the Corporate Governance and Nominating Committee.

Dentsply Sirona Announces Planned Board Succession

CHARLOTTE, N.C., Sept. 25, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host its Investor Day in Charlotte, North Carolina, on November 9, 2023. The event will begin at 8:30 AM ET.

News for DENTSPLY SIRONA Stock (XRAY)